Name: Seres Therapeutics, Inc. (MCRB) Balance Sheet
Creator: FinSpry

Seres Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Seres Therapeutics, Inc. (MCRB) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	30.79	127.97	181.34	290.71	116.05	94.82	85.82
Short-Term Investments	0.00	0.00	18.31	110.70	137.57	0.00	0.00
Cash & Short-Term Investments	30.79	127.97	181.34	290.71	253.62	94.82	85.82
Accounts Receivable	2.07	0.00	0.00	0.00	9.39	1.79	0.00
Inventory	0.00	29.65	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.81	8.05	12.53	12.92	5.77	0.00	0.00
Total Current Assets	38.67	175.41	194.76	303.63	268.78	100.19	92.67
Non-Current Assets
Property, Plant & Equipment (Net)	92.44	108.03	133.97	36.15	22.94	11.36	26.29
Long-Term Investments	0.00	0.00	0.00	0.50	49.83	0.00	0.00
Other Non-Current Assets	8.70	75.16	20.05	14.59	1.40	1.40	1.51
Total Non-Current Assets	101.14	183.19	154.02	51.23	74.16	12.76	27.81
Total Assets	139.81	358.60	348.78	354.86	342.94	132.44	120.47
Current Liabilities
Accounts Payable	4.08	3.64	17.44	13.74	4.02	4.86	21.62
Short-Term Debt	8.67	0.00	0.46	0.00	0.45	0.00	0.00
Current Portion of Long-Term Debt	0.00	0.00	0.46	0.00	0.45	0.00	0.00
Accrued Liabilities	10.72	22.51	25.07	24.00	14.23	0.00	0.00
Deferred Revenue	0.00	7.73	4.26	16.82	22.60	0.00	0.00
Other Current Liabilities	17.75	66.92	64.10	45.09	14.23	10.88	3.14
Total Current Liabilities	41.22	98.66	85.60	82.26	46.42	45.99	42.04
Non-Current Liabilities
Long-Term Debt	82.97	101.54	158.53	42.60	24.64	40.32	0.00
Other Non-Current Liabilities	1.84	1.63	1.44	28.31	1.00	21.46	7.42
Total Non-Current Liabilities	84.80	304.80	252.41	157.91	144.38	155.73	126.48
Total Liabilities	126.03	403.46	338.00	223.35	168.19	180.76	168.52
Stockholders' Equity
Common Stock	0.17	0.14	0.13	0.09	0.09	0.00	0.00
Retained Earnings	-978.10	-978.24	-864.52	-614.41	-548.78	-459.65	-389.37
Accumulated Other Comprehensive Income	0.00	0.00	-0.01	-0.06	-0.05	0.00	0.00
Additional Paid-in Capital	991.71	933.24	875.18	745.83	723.48	411.26	341.28
Shares Outstanding	8.65	6.75	6.26	4.59	0.00	0.00	0.00
Total Stockholders' Equity	13.78	-44.86	10.78	131.51	174.75	-48.32	-48.05
Total Liabilities & Equity	139.81	358.60	348.78	354.86	342.94	132.44	120.47